Pharmaknowl - Logo

Product Recall in Saudi Arabia

Share it on

The Author

Nouf Almadallah

Pharmacists, (Pharm D). Working as Qualified Person For Pharmacovigilance (QPPV) in PharmaKnowl.

In 2023, the SFDA issued a new regulation for product recall from the market. The objective is to ensure that in the event of a necessary recall, the recall operations are effectively and efficiently carried out by the responsible supplier through their pharmacovigilance and other related departments such as the supply chain and higher management.

Scope

  • Drugs intended for use in humans and animals.
  • Human herbal product.
  • Human health product.

Definitions

Recall action is the term used to describe an action taken to resolve a problem with a product currently in use or available for use because of deficiencies in its quality, safety, or efficacy.

The Responsible Supplier is the entity that initiates a recall process and has primary responsibility for the supply of products in Saudi Arabia. It includes manufacturers, marketing authorization holders, scientific offices, importers, agents, distributors, and retailers.

Recall Action Classification

  • Class 1: The defect presents a life-threatening or serious risk to health.
  • Class 2: The defect may cause mistreatment or temporary harm to the patient, but the life-threatening or serious risk probability is remote.
  • Class 3: The defect is unlikely to cause harm to the patient, and the recall is carried out for other reasons.

Recall Action Level

  • Wholesale level
  • Retail and hospital level.
  • Consumer or patient level

Recall Action Process

Phase 1. Initiation  Notification and problem identificationThe classification and level of recall action are determined initially by the responsible supplier based on the assessment of the health hazard presented by the product. However, SFDA will review the classification and level of recall action and adjust it where appropriate
Hazard/risk assessment, recall action assessment and agreementAfter receiving a recall letter from SFDA, the responsible supplier should initiate recall action and contact the affected entities immediately.
Phase 2. ImplementationCommunication and distribution of recall letterAfter receiving a recall letter from SFDA, the responsible supplier should initiate recall action and contact with affected entities immediately.
Communication timelinesProgress reports should be provided to SFDA during the recall. The progress reports should be submitted daily. Recall progress reports should normally specify: the number of recipients notified of the recall, the number of respondents, the number of non-respondents, the next expected follow-up date with non-responders, the method of communication, and the quantity of stock returned or corrected.  
Phase 3.
Review / Close Out –
Progress reportProgress reports should be provided to SFDA during the recall. The progress reports should be submitted daily. Recall progress reports should normally specify: the number of recipients notified of the recall, the number of respondents, the number of non-respondents, the next expected follow-up date with non-responders, the method of communication, and the quantity of stock returned or corrected.  
Final reportThe recall strategy should define the method and content for all communications associated with the recall. The content of recall communication includes a description of the product, the reason for the recall, and the actions to be taken by the recipient, including instructions to stop further distribution or use immediately, instructions for how to recall the affected product, instructions to all entities involved in the distribution chain to notify their customers of the recall and to provide instructions on how to proceed to recall the affected product, the expected recall action termination date (the maximum period for recall action is 12 weeks from the receipt of the recall letter)
Need Support?

Ready to start your project? Our full-time SFDA consultants look forward to helping you navigate the SFDA regulations. Start now by requesting a service or scheduling a meeting!

Start Here

The Author

Nouf Almadallah

Pharmacists, (Pharm D). Working as Qualified Person For Pharmacovigilance (QPPV) in PharmaKnowl.

Pharmaknowl - Subscribe to our Newsletter

Subscribe to our Newsletter to receive the latest SFDA news and insights.

Hidden
Hidden

Insights

Discover All Insights

Exploratory Consultation Schedule an online meeting to discuss your business needs.

Pharmaknowl - Find out how we can help your business
© PhamaKnowl - 2024, All Rights Reserved
Pharmaknowl - Logo